Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by MartialArtson May 23, 2018 10:43am
137 Views
Post# 28069203

RE:Aphria

RE:Aphria
The trading patterns on Aphria are identical to the trading patterns on CanniMed before that hostile take over.  So yes, something does indicate someone is attempting to take it over and wants to pay as little as possible for it.

Keep in mind the market cap for APH is nearly identical to that of LEAF, a recent take over of Aurora. Both in the $2.5-2.7B market cap.

Keep in mind that Aphria has three times the production today and over twice the future production of MedRelief plus its grow cost is about 1/3.

APH will get taken over.  The question is, will it be a peer, Diageo (my bet), pharma or tabacco.

There's only Canopy and Aphria with 6 digits KG grow capability in 2019.  It's like buying a house in a hot neighbourhood and there's only two available. Prices go up because there's more buyers than sellers.

What we are seeing on the stock price right now is a short term abnormaly.  Buy the dips.

Bullboard Posts